These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Engineering vascularized bone: osteogenic and proangiogenic potential of murine periosteal cells. van Gastel N, Torrekens S, Roberts SJ, Moermans K, Schrooten J, Carmeliet P, Luttun A, Luyten FP, Carmeliet G. Stem Cells; 2012 Nov; 30(11):2460-71. PubMed ID: 22911908 [Abstract] [Full Text] [Related]
3. Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, Lanzoni G, Cantoni S, Cavallini C, Bianchi F, Tazzari PL, Pasquinelli G, Foroni L, Ventura C, Grossi A, Bagnara GP. BMC Dev Biol; 2007 Feb 21; 7():11. PubMed ID: 17313666 [Abstract] [Full Text] [Related]
8. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells. Both SK, van Apeldoorn AA, Jukes JM, Englund MC, Hyllner J, van Blitterswijk CA, de Boer J. J Tissue Eng Regen Med; 2011 Mar 21; 5(3):180-90. PubMed ID: 20718035 [Abstract] [Full Text] [Related]
11. Contrasting effects of vasculogenic induction upon biaxial bioreactor stimulation of mesenchymal stem cells and endothelial progenitor cells cocultures in three-dimensional scaffolds under in vitro and in vivo paradigms for vascularized bone tissue engineering. Liu Y, Teoh SH, Chong MS, Yeow CH, Kamm RD, Choolani M, Chan JK. Tissue Eng Part A; 2013 Apr 21; 19(7-8):893-904. PubMed ID: 23102089 [Abstract] [Full Text] [Related]
15. Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells. Lee EJ, Lee HN, Kang HJ, Kim KH, Hur J, Cho HJ, Lee J, Chung HM, Cho J, Cho MY, Oh SK, Moon SY, Park YB, Kim HS. Tissue Eng Part A; 2010 Feb 21; 16(2):705-15. PubMed ID: 19895342 [Abstract] [Full Text] [Related]
17. A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo- and chondrogenic precursors. Hudson JE, Mills RJ, Frith JE, Brooke G, Jaramillo-Ferrada P, Wolvetang EJ, Cooper-White JJ. Stem Cells Dev; 2011 Jan 21; 20(1):77-87. PubMed ID: 20446813 [Abstract] [Full Text] [Related]
18. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Fuchs S, Ghanaati S, Orth C, Barbeck M, Kolbe M, Hofmann A, Eblenkamp M, Gomes M, Reis RL, Kirkpatrick CJ. Biomaterials; 2009 Feb 21; 30(4):526-34. PubMed ID: 18977026 [Abstract] [Full Text] [Related]
19. In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(d,l-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds. Kim S, Kim SS, Lee SH, Eun Ahn S, Gwak SJ, Song JH, Kim BS, Chung HM. Biomaterials; 2008 Mar 21; 29(8):1043-53. PubMed ID: 18023477 [Abstract] [Full Text] [Related]